“[18F]FDG PET Immunotherapy Radiomics Signature (iRADIOMICS) Predicts Response of Non-Small-Cell Lung Cancer Patients Treated With Pembrolizumab”. 2020. Radiology and Oncology 54 (3): 285-94. https://radioloncol.com/index.php/ro/article/view/3452.